THERIVA BIOLOGICS, INC. (TOVX)
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
STERIS Announces Dividend of $0.63 per share
Artesian Announces 2% Increase in Quarterly Common Stock Dividend
Upexi to Host Third Quarter 2026 Earnings Call on May 12th at 5:30 p.m. ET
Andrew T. Scribner Elected Executive Vice President and Chief Financial Officer of CF Industries Holdings, Inc.
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
Phibro Animal Health Corporation Declares Quarterly Dividend
Midland States Bancorp, Inc. Announces Common Stock and Preferred Stock Dividends
Intel Corporation to Participate in Upcoming Investor Conferences
New Product Launches Drive Alcons First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds